This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

FTC imposes conditions on AbbVie's acquisition of Allergan

( May 6, 2020, 00:22 GMT | Official Statement) -- MLex Summary: Pharmaceutical companies AbbVie and Allergan have agreed to divest assets to settle Federal Trade Commission charges that AbbVie’s proposed $63 billion acquisition of Allergan would violate federal antitrust law, the agency said. The commission voted 3-2 to issue the complaint and accept the proposed consent order for public comment, with Chairman Joe Simons and Commissioners Noah Phillips and Christine Wilson voting in favor and Commissioners Rohit Chopra and Rebecca Slaughter — the commission's two Democratic members — dissenting.Statement follows below:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login